Aspirin for Cholangiocarcinoma Prevention: New Targets to Shift the Dogma From Ascertained Risk to Possible Prevention

Hepatology - United States
doi 10.1002/hep.28999
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley